Quarterly results
We announce our results on a quarterly basis.
This section contains details of our results announcements, to view and download, along with links to related webcasts and presentations.
Results from previous years are archived by date, and can be accessed from the tabs below.
GSK delivers 2009 EPS of 121.2p before major restructuring*
and dividend of 61p (+4p)
- Strategy supports return to sales growth (+3%)
- Sustained R&D productivity; with further actions to improve returns
GSK delivers Q3 EPS of 28.5p before major restructuring*
and dividend of 15p up 7%
- Return to sales growth with Q3 turnover +3% CER; +15% sterling
- Continued improvement expected in Q4
GSK delivers Q2 EPS of 31p before major restructuring*
and dividend of 14p up 8%
- Improving performance to continue in second half of 2009
- Good progress made to deliver strategic priorities
GSK delivers Q1 EPS of 26.3p before major restructuring*
and increased dividend of 14p